Compare Charles River Laboratories Intl. Inc (CRL) vs Futu Holdings Ltd (FUTU) Price & Performance

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Futu Holdings trades at $96.35, showing minimal daily movement. The stock faces a bearish technical signal with support near $95 and resistance at $97. Fundamentally, the company reported strong 2025 revenue of $22.85 billion and net income of $11.34 billion, with a robust net margin of 41.83%. However, recent earnings misses and a class action lawsuit alleging securities fraud have created significant headwinds.

The outlook is clouded by legal risks and inconsistent earnings performance, despite attractive valuation ratios like a P/E of 10.65. Analyst consensus remains cautiously optimistic with a majority 'Buy' rating, but investors must weigh solid profitability against substantial regulatory and litigation overhangs that could pressure the stock in the near term.